TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T05849	Gastrin/cholecystokinin type B receptor	D04HQT	proglumide	Phase 2	4922	C18H26N2O4	334.4	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1	IC50 = 900000 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	B0OJM5	(3S)-3-{[(2S)-1-[(2S)-2-{2-[(2R)-2-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanehydrazido]-1-oxo-3-phenylpropan-2-yl]carbamoyl}-3-[(2S)-2-[(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-(1H-indol-2-yl)propanamido]hexanamido]propanoic acid	Investigative	44418923	C58H73N11O13	1132.3	CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@@H](CC4=CC5=CC=CC=C5N4)NC(=O)OC(C)(C)C	IC50 = 100000000000000 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	B1DPR5	(3S)-3-[(2S)-2-[(2R)-2-Amino-3-(1H-indol-2-yl)propanamido]hexanamido]-3-{[(2S)-1-[(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanehydrazido]-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid	Investigative	44418924	C53H65N11O11	1032.099	CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@@H](CC4=CC5=CC=CC=C5N4)N	IC50 = 107000000000000 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	B7GEA9	(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-Acetamido-6-(pent-4-ynoylamino)hexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	Investigative	73345878	C59H82N16O13	1223.4	CCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCNC(=O)CCC#C)NC(=O)C	IC50 = 4600000 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	BC0PG5	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Phe-D-Asp-D-Nle-Trp-Boc	Investigative	16100408	C58H73N11O13	1132.3	CCCC[C@H](C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@H](CC4=CC5=CC=CC=C5N4)NC(=O)OC(C)(C)C	IC50 = 15135612484 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	BCK3U8	H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-Boc	Investigative	16100406	C58H73N11O13	1132.3	CCCC[C@H](C(=O)N[C@@H](CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)OC(C)(C)C	IC50 = 912000000000000 nM	Non binder
T05849	Gastrin/cholecystokinin type B receptor	D0I9PH	H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-H	Investigative	16100409	C53H65N11O11	1032.099	CCCC[C@H](C(=O)N[C@@H](CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC5=CC=CC=C5)N	IC50 = 74100000000000 nM	Non binder